HeXell-2020
/ HeXun Biosciences
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 28, 2025
Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome
(clinicaltrials.gov)
- P1 | N=12 | Not yet recruiting | Sponsor: Hexun Biosciences Co., LTD.
New P1 trial • Geriatric Disorders
August 23, 2025
Safety and Preliminary Effectiveness Study of Mesenchymal Stem Cells, HeXell-2020, in Patients With Stable Coronary Artery Disease
(clinicaltrials.gov)
- P1/2 | N=39 | Not yet recruiting | Sponsor: Hexun Biosciences Co., LTD.
New P1/2 trial • Cardiovascular • Coronary Artery Disease
1 to 2
Of
2
Go to page
1